FULCRUM THERAPEUTICS INC. - COMMON STOCK
3,6350
13-февраля-25 11:40:56
15 мин. задержка
Акции
+0,0750
+2,11%
Сегодняшний диапазон
3,5150 - 3,6500
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
Fulcrum Therapeutics Announces Proposed Public Offering of Common Stock
17 янв 2023 16:01:00 Источник Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
13 янв 2023 17:00:00 Источник Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Provides Business Update and 2023 Outlook
04 янв 2023 07:02:00 Источник Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Announces CEO Transition
04 янв 2023 07:01:00 Источник Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 дек 2022 17:20:59 Источник Nasdaq GlobeNewswire
-
Fulcrum Therapeutics to Participate at Upcoming 2022 BofA Securities Biotech SMID Cap Conference
01 дек 2022 16:01:00 Источник Nasdaq GlobeNewswire
-
Fulcrum Therapeutics® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11 ноя 2022 18:33:20 Источник Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Announces Recent Business Highlights and Third Quarter 2022 Financial Results
08 ноя 2022 07:17:58 Источник Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Appoints Chief Medical Officer and Chief Scientific Officer
07 ноя 2022 17:00:00 Источник Nasdaq GlobeNewswire
-
02 ноя 2022 07:05:00 Источник Nasdaq GlobeNewswire
-
Fulcrum Therapeutics® to Participate at Upcoming November Investor Conferences
01 ноя 2022 17:29:02 Источник Nasdaq GlobeNewswire
-
12 окт 2022 07:30:00 Источник Nasdaq GlobeNewswire
-
Fulcrum Therapeutics® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07 окт 2022 17:00:00 Источник Nasdaq GlobeNewswire
-
Fulcrum Therapeutics® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
09 сен 2022 17:00:00 Источник Nasdaq GlobeNewswire
-
Fulcrum Therapeutics to Participate at Upcoming September Investor Conferences
06 сен 2022 16:01:00 Источник Nasdaq GlobeNewswire
-
Fulcrum Therapeutics® to Participate at the Upcoming Stifel 2022 Biotech Summer Summit
16 авг 2022 07:05:00 Источник Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Announces Pricing of Public Offering of Common Stock
15 авг 2022 21:28:02 Источник Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Announces Proposed Public Offering of Common Stock
15 авг 2022 16:08:15 Источник Nasdaq GlobeNewswire
-
Fulcrum Therapeutics Announces Second Quarter 2022 Financial Results and Business Update
11 авг 2022 07:00:02 Источник Nasdaq GlobeNewswire
-
04 авг 2022 08:07:44 Источник Nasdaq GlobeNewswire